You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

CLINICAL TRIALS PROFILE FOR NATEGLINIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for NATEGLINIDE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00097786 ↗ Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications Completed Novartis Pharmaceuticals Phase 3 2002-01-01 This study is a test of the safety and effectiveness of two drugs, one for diabetes and one for hypertension, in keeping patients with high lab values of glucose from progressing to frank diabetes and developing cardiovascular complications. People in this study cannot have frank diabetes but are considered "borderline" based on blood tests. People in the study take none, one or both of the drugs and do not know which one(s) they are taking.
NCT00189774 ↗ Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients Completed Ajinomoto USA, INC. Phase 2/Phase 3 1969-12-31 The purpose of this study is to investigate the superiority of nateglinide over placebo for inadequately controlled type 2 diabetic patients with pioglitazone treatment.
NCT00189774 ↗ Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients Completed Astellas Pharma Inc Phase 2/Phase 3 1969-12-31 The purpose of this study is to investigate the superiority of nateglinide over placebo for inadequately controlled type 2 diabetic patients with pioglitazone treatment.
NCT00212290 ↗ Insulin Resistance and Central Nervous System (CNS) Function in Type 2 Diabetes Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Phase 4 2002-11-01 The purpose of this study is to examine the effects of treating insulin resistance on memory and attention, brain glucose utilization, and proteins in spinal fluid.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for NATEGLINIDE

Condition Name

Condition Name for NATEGLINIDE
Intervention Trials
Type 2 Diabetes Mellitus 7
Diabetes Mellitus, Type 2 6
Type 2 Diabetes 3
Diabetes Mellitus 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for NATEGLINIDE
Intervention Trials
Diabetes Mellitus 17
Diabetes Mellitus, Type 2 15
Insulin Resistance 2
Heart Failure 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for NATEGLINIDE

Trials by Country

Trials by Country for NATEGLINIDE
Location Trials
United States 5
Korea, Republic of 5
Japan 5
Canada 3
China 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for NATEGLINIDE
Location Trials
New York 1
Georgia 1
Florida 1
New Jersey 1
Washington 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for NATEGLINIDE

Clinical Trial Phase

Clinical Trial Phase for NATEGLINIDE
Clinical Trial Phase Trials
Phase 4 14
Phase 3 3
Phase 2/Phase 3 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for NATEGLINIDE
Clinical Trial Phase Trials
Completed 22
Recruiting 1
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for NATEGLINIDE

Sponsor Name

Sponsor Name for NATEGLINIDE
Sponsor Trials
Novartis Pharmaceuticals 5
Drug Safety and Effectiveness Network, Canada 3
Canadian Network for Observational Drug Effect Studies, CNODES 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for NATEGLINIDE
Sponsor Trials
Other 34
Industry 16
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.